IN THE PRESS AND MAKING NEWS.
Virolens vs Other COVID-19 Testing Modalities
Since the emergence of the SARS-CoV-2 delta strain and widespread vaccination, the landscape of viral detection has changed immensely. Firstly, the delta strain has a rapid onset of infection, with peak viremia (and therefore infectivity) before symptoms appear. Secondly, vaccination prevents severe disease in most people, but does not preclude infections in vaccinated people. Indeed, these people can, even when free of symptoms, pass the virus on to others.
Virolens vs Other COVID-19 Testing Modalities (Part 2)
Since the emergence of the SARS-CoV-2 delta strain and widespread vaccination, the landscape of viral detection has changed immensely. Firstly, the delta strain has a rapid onset of infection, with peak viremia (and therefore infectivity) before symptoms appear. Secondly, vaccination prevents severe disease in most people, but does not preclude infections in vaccinated people. Indeed, these people can, even when free of symptoms, pass the virus on to others.
Instant Covid Testing - Virolens machine shows it to be at least as sensitive as RT-PCR, and over 99.9% specific to SARS-CoV-2
KeyOptions announces the appointment of Dr. Kerry Mills as Chair of the ‘International Virolens Research Consortium.
KeyOptions announces the appointment of Dr. Kerry Mills as Chair of the ‘International Virolens Research Consortium’.
SYDNEY AUSTRALIA – September 2, 2021: KeyOptions, an Australian technology company, today announced the appointment of Dr. Kerry Mills to the International Virolens Research Consortium (IVRC) Board of Directors, effective September 6, 2021.
Dr. Mills will serve as the IVRC Chair and will take the reins during this critical period as the Consortium is established. Dr. Mills will also act as temporary head to the IVRC Scientific Committee of the Board.